Clorox Q1 2025 Adj. EPS $1.86 Beats $1.39 Estimate, Sales $1.762B Beat $1.646B Estimate
Portfolio Pulse from Benzinga Newsdesk
Clorox reported strong Q1 2025 earnings, with adjusted EPS of $1.86 beating estimates by 33.81% and sales of $1.762 billion surpassing expectations by 7.05%. This marks a 27.13% increase in sales compared to the same period last year.
October 30, 2024 | 8:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Clorox's Q1 2025 earnings significantly exceeded expectations, with EPS of $1.86 and sales of $1.762 billion, indicating strong financial performance and a 27.13% increase in sales year-over-year.
Clorox's earnings and sales both exceeded analyst estimates, indicating strong financial health and potential positive investor sentiment. The significant year-over-year sales growth further supports a positive outlook for the stock in the short term.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100